Again Technology Holdings Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
69
Ending by 2030
Feb 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 28, 2026The maintenance fee for Novel Car Enzymes and Improved Production of Fatty Alcohols (US 10,301,603) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
- 2 fees due Dec 9 to 23, 2026 · next Dec 9
- 4 fees due Jan 16 to 25, 2027 · next Jan 16
- 3 fees due Feb 4 to 27, 2027 · next Feb 4
- 5 fees due Mar 12 to 17, 2027 · next Mar 12
- 2 fees due Apr 8 to 22, 2027 · next Apr 8
- 6 fees due May 3 to 26, 2027 · next May 3
- 4 fees due Jun 1 to 29, 2027 · next Jun 1
- 5 fees due Aug 13 to 25, 2027 · next Aug 13
- 3 fees due Sep 19 to 24, 2027 · next Sep 19
- 2 fees due Oct 21 to 26, 2027 · next Oct 21
- 2 fees due Nov 5 to 14, 2027 · next Nov 5
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
- 1 term has ended since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,283,143 | Enhanced Production of Fatty Acid Derivatives In force · Medium confidence | In force | Medium confidence | |
| US 9,017,984 | Enhanced Production of Fatty Acid Derivatives In force · High confidence | In force | High confidence | |
| US 10,017,455 | Enhanced Production of Fatty Acid Derivatives In force · High confidence | In force | High confidence | |
| US 8,110,670 | Enhanced Production of Fatty Acid Derivatives In force · High confidence | In force | High confidence | |
| US 8,949,032 | Multicellular Metabolic Models and Methods In force · Medium confidence | In force | Medium confidence | |
| US 8,470,582 | Methods and organisms for the growth-coupled production of 1,4-Butanediol In force · High confidence | In force | High confidence | |
| US 8,357,520 | Compositions and Methods for the Biosynthesis of 1,4-Butanediol and Its Precursors In force · Medium confidence | In force | Medium confidence | |
| US 8,889,399 | Compositions and Methods for the Biosynthesis of 1,4-Butanediol and Its Precursors In force · High confidence | In force | High confidence | |
| US 8,969,054 | Compositions and Methods for the Biosynthesis of 1,4-Butanediol and Its Precursors In force · Low confidence | In force | Low confidence | |
| US 9,487,803 | Compositions and Methods for the Biosynthesis of 1,4-Butanediol and Its Precursors In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 183: 53 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.